| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4168349
Max Phase: Preclinical
Molecular Formula: C24H27NO5
Molecular Weight: 409.48
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1cc(/C=C2\CN(C)C/C(=C\c3cc(OC)cc(OC)c3)C2=O)cc(OC)c1
Standard InChI: InChI=1S/C24H27NO5/c1-25-14-18(6-16-8-20(27-2)12-21(9-16)28-3)24(26)19(15-25)7-17-10-22(29-4)13-23(11-17)30-5/h6-13H,14-15H2,1-5H3/b18-6+,19-7+
Standard InChI Key: UINOSMFXESPUJK-JRGWAENISA-N
Associated Targets(non-human)
Luciferin 4-monooxygenase 66902 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 409.48 | Molecular Weight (Monoisotopic): 409.1889 | AlogP: 3.70 | #Rotatable Bonds: 6 |
| Polar Surface Area: 57.23 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 4.97 | CX LogP: 3.65 | CX LogD: 3.65 |
| Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.68 | Np Likeness Score: -0.16 |
References
| 1. Deck LM, Hunsaker LA, Vander Jagt TA, Whalen LJ, Royer RE, Vander Jagt DL.. (2018) Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin., 143 [PMID:29223100] [10.1016/j.ejmech.2017.11.048] |
Source
Source(1):